Advertisement

Organisation › Details
Peptone (Group)
Innovative drug discovery pioneers Peptone are applying advanced biophysics, atomic-level experimental approaches, cutting-edge supercomputing and machine learning to the challenge of biopharmaceutical research and development. By bringing these proprietary approaches together, we are exploring the world of intrinsically disordered proteins (IDPs) – proteins without a fixed structure that play a significant role in health and disease – opening up the possibility of novel therapeutics against an entire class of high value and previously undruggable targets. *
![]() |
Start | 2018-04-06 established |
Today | Peptone Ltd. | |
![]() |
Industry | artificial intelligence (AI) / machine learning (ML) |
![]() |
Person | Tamiola, Kamil (Peptone 201804– CEO + Co-Founder) |
![]() |
Region | London, Greater London |
Country | United Kingdom (GB) | |
Street | 370 Grays Inn Road The Lighthouse Building | |
City | WC1X 8BB London | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Peptone Ltd.. (9/9/22). "Press Release: Peptone Closes a $40M Series-A Funding Round Led by F-Prime and Bessemer Venture Partners". London. | ||
Record changed: 2023-07-10 |
Advertisement

More documents for Peptone (Group)
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top